Copyright © Fidelis Security. All rights reserved.
-
Privacy PolicyPrivacy Policy
-
Terms of ServiceTerms of Service
-
Trust CenterTrust Center
-
SecuritySecurity
Get access to our exclusively curated how-to guides to help you navigate through the world of cybersecurity and its adversaries.
Lyell Immunopharma is a South San Francisco-based, publicly traded cell therapy company (LYEL). Their T cell reprogramming technology focuses on the mastery of T cells to cure patients with solid tumors. They apply proprietary genetic and epigenetic reprogramming technology platforms to address barriers present in solid tumors in order to develop new medicines with improved, durable, and potentially curative clinical outcomes.
Discover how to secure hybrid cloud deployments, bridging cloud and...
Read How ToLearn to secure cloud-native applications with ease. Explore architecture, automation,...
Read How ToLearn to automate security controls in Kubernetes environments. Get insights...
Read How ToNavigate the network DLP challenge effectively. Learn about key features...
Read How ToDiscover how to ensure a secure transition to cloud environments....
Read How ToLeverage Cyber Deception Techniques and Technologies for Effective Defense Strategies ...
Read How ToJoin our newsletter to stay up to date on features and releases.